Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Cardio Casesadult-congenital-heart-disease

Cardio Cases · adult-congenital-heart-disease

Coarctation of the aorta in adults — practice case: recoarctation before pregnancy

Practice case: a woman with childhood patch repair of coarctation, hypertension and a raised limb gradient who plans pregnancy; re-coarctation and repair-site complications, cross-sectional imaging and ambulatory blood pressure, ESC 2024 and ACC/AHA 2025 repair rows, pregnancy risk (ACC/AHA 2025 Table 10, ESC 2025 Table 12) and follow-up after stenting.

practice case discussion (not a real patient)3 min readVerification in progress

Target exams

  • EECC
  • ABIM Cardiovascular Disease Certification
On this page
Study tools

Target exams

  • EECC
  • ABIM Cardiovascular Disease Certification
Prompt
A woman of 30 with childhood coarctation repair, hypertension and a raised arm-to-leg gradient, planning pregnancy.

Presentation

Practice case (not a real patient). A 30-year-old woman had coarctation of the aorta repaired with a patch in childhood and has not been seen in a cardiology clinic for years. She plans a pregnancy next year.[1][7] Her right-arm blood pressure is raised, the systolic difference between her right arm and leg is 30 mmHg, and her femoral pulses are delayed. She has no cardiac symptoms.[1]

Step 1 — What is going on?

Discussion:

  • ESC 2020: an increased systolic gradient (≥20 mmHg) between upper and lower extremities indicates re-coarctation and warrants invasive assessment for confirmation and treatment; radiofemoral pulse delay also indicates significant coarctation.[1]
  • Patch repairs are at particular risk of repair-site aneurysms (ESC 2020), and ACC/AHA 2025 lists re-coarctation, aneurysms or pseudoaneurysms at the repair site, and dissection among the vascular complications of repaired coarctation.[1][2]
  • Hypertension at rest or during exercise is common even after successful treatment, and recurring or residual coarctation may induce or aggravate it (ESC 2020).[1]

Step 2 — Investigations

Discussion:

  • ACC/AHA 2025: in adults with repaired coarctation, periodic cross-sectional imaging is recommended to screen for recurrent coarctation, aortic root or ascending aneurysms and vascular complications of repair (COR 1, LOE B-NR); CMR is preferred because it avoids radiation.[2]
  • ESC 2020: CMR and CCT depict the site, extent and degree of narrowing, the arch and head and neck vessels and collaterals, and detect aneurysms, false aneurysms, restenosis or residual stenosis.[1]
  • Right-arm ambulatory blood pressure should be considered for the diagnosis of hypertension (ESC 2020 table footnote); ACC/AHA 2025 calls ambulatory measurement reasonable to diagnose hypertension and monitor treatment (COR 2a, LOE B-NR).[1][2]
  • Echocardiography shows LV function and hypertrophy and associated abnormalities (ESC 2020); a bicuspid valve should be sought, since ACC/AHA 2022 says it coexists in at least 50% of cases.[1][4]

CMR shows a severe recoarctation at the repair site without an aneurysm, and catheterisation confirms a peak-to-peak gradient of 32 mmHg; stenting is technically feasible.[2][1]

Step 3 — Treatment before pregnancy

Discussion:

  • ESC 2024: coarctation or re-coarctation repair is indicated in patients with hypertension with an increased non-invasive gradient confirmed with invasive measurement (peak-to-peak >20 mmHg), with a preference for stenting when technically feasible (Class I, Level C).[3]
  • ACC/AHA 2025: surgical or transcatheter stent therapy is recommended for anatomically and hemodynamically significant native or repaired coarctation to prevent irreversible LV dysfunction from chronic pressure overload (COR 1, LOE B-NR).[2]
  • Pregnancy: ACC/AHA 2025 Table 10 lists severe native coarctation or recoarctation as significantly high risk for maternal complications, and ESC 2025 Table 12 advises pre-pregnancy CMR and treatment of residual lesions.[2][7]
  • ACC/AHA 2022: after a previous open repair, an endovascular approach to recoarctation, aneurysm or pseudoaneurysm avoids reoperation, assuming adequate iliofemoral access and no involvement of the supra-aortic trunks.[4]

Step 4 — Pregnancy and follow-up

Discussion:

  • ESC 2025 Table 12 for coarctation: close blood pressure monitoring, also early post-partum; treat hypertension; vaginal delivery preferred unless aneurysm, heart failure or severe hypertension.[7]
  • It lists a higher complication risk with residual obstruction (gradient >20 mmHg, aortic lumen <12 mm), clinical signs of heart failure, LVEF <40% or NYHA class >1, a higher miscarriage rate, and pre-term birth and low birth weight in 9%.[7]
  • After the stent, CT angiography rather than CMR should be used for imaging because of stent artefacts on CMR (ACC/AHA 2025), and ESC 2024 recommends lifelong follow-up in native or repaired coarctation, including regular CCT/CMR of the aorta every 3–5 years adapted to clinical status and previous imaging findings (Class I, Level B).[2][3]
  • If hypertension persists without hemodynamically significant coarctation, GDMT is recommended to maintain controlled resting and ambulatory blood pressure (ACC/AHA 2025, COR 1, LOE B-NR).[2]

Learning points

  • A raised upper-to-lower limb gradient after repair points to re-coarctation and needs invasive confirmation (ESC 2020).[1]
  • Severe recoarctation is high risk in pregnancy, so the residual lesion is treated before pregnancy (ACC/AHA 2025 Table 10; ESC 2025 Table 12).[2][7]
  • After a stent, image with CT angiography (ACC/AHA 2025).[2]
References5ShowHide
  1. [1]Baumgartner H, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J, 2021.PMID 32860028
  2. [2]Gurvitz M, et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2026.PMID 41411375
  3. [3]Mazzolai L, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J, 2024.PMID 39210722
  4. [4]Isselbacher EM, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2022.PMID 36322642
  5. [7]De Backer J, et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J, 2025.PMID 40878294
PreviousACHD general principles — practice case: a systemic right ventricle after the Mustard operationadult-congenital-heart-diseaseNextSecundum ASD with pulmonary arterial hypertension — case discussionadult-congenital-heart-disease